TETEC Tissue Engineering Technologies AG
2 products tracked · names used in filings: TETEC Tissue Engineering Technologies AG
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 11 Nov 2025🇪🇺 Application withdrawn (EU)
Jelrix (autologous cartilage-derived articular chondrocytes, in-vitro expanded): EU application withdrawn
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Jelrix autologous cartilage-derived articular chondrocytes, in-vitro expanded | Application withdrawn | |
| 🇪🇺 | Artobend autologous human chondrocytes in vitro expanded | Application withdrawn |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.